Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer—a network meta-analysis
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy and safety of oral anticoagulants in atrial fibrillation patients with cancer—a network meta-analysis
Authors
Keywords
Atrial fibrillation, Cancer, Oral anticoagulants, Meta-analysis
Journal
HEART FAILURE REVIEWS
Volume -, Issue -, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-08-14
DOI
10.1007/s10741-019-09844-8
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- 2019 AHA/ACC/HRS Focused Update of the 2014 AHA/ACC/HRS Guideline for the Management of Patients With Atrial Fibrillation
- (2019) Craig T. January et al. HEART RHYTHM
- Comparative efficacy and safety of mineralocorticoid receptor antagonists in heart failure: a network meta-analysis of randomized controlled trials
- (2019) Pingping Yang et al. HEART FAILURE REVIEWS
- To teach an old dog new tricks: The limits of CHA2DS2-VASc in patients with atrial fibrillation and cancer
- (2018) Xiaoxi Yao et al. European Journal of Preventive Cardiology
- Effect of Non-vitamin K Antagonist Oral Anticoagulants in Atrial Fibrillation Patients with Newly Diagnosed Cancer
- (2018) Kyu Kim et al. Korean Circulation Journal
- Atrial Fibrillation and Malignancy: The Clinical Performance of Non–Vitamin K Oral Anticoagulants—A Systematic Review
- (2018) Roberta Bottino et al. SEMINARS IN THROMBOSIS AND HEMOSTASIS
- Efficacy and safety of anticoagulant agents in patients with venous thromboembolism and cancer: A network meta-analysis
- (2018) Maria Cristina Vedovati et al. THROMBOSIS RESEARCH
- Efficacy and Safety of Edoxaban in Patients With Active Malignancy and Atrial Fibrillation: Analysis of the ENGAGE AF‐TIMI 48 Trial
- (2018) Christina L. Fanola et al. Journal of the American Heart Association
- Atrial fibrillation in cancer patients: Hindsight, insight and foresight
- (2017) Benoîte Mery et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- CHA 2 DS 2 -VASc Score (Congestive Heart Failure, Hypertension, Age ≥75 [Doubled], Diabetes Mellitus, Prior Stroke or Transient Ischemic Attack [Doubled], Vascular Disease, Age 65–74, Female) for Stroke in Asian Patients With Atrial Fibrillation
- (2017) Tae-Hoon Kim et al. STROKE
- Cancer, atrial fibrillation, and stroke
- (2017) Tess Fitzpatrick et al. THROMBOSIS RESEARCH
- Are New Oral Anticoagulants Ready for Use in Patients With Cancer?
- (2017) Paul C. Hendrie et al. Journal of the National Comprehensive Cancer Network
- Antithrombotic Therapy for VTE Disease
- (2016) Clive Kearon et al. CHEST
- 2016 ESC Guidelines for the management of atrial fibrillation developed in collaboration with EACTS
- (2016) Paulus Kirchhof et al. EUROPEAN HEART JOURNAL
- Bleeding risk and major adverse events in patients with cancer on oral anticoagulation therapy
- (2016) Yong-Joon Lee et al. INTERNATIONAL JOURNAL OF CARDIOLOGY
- New oral anticoagulants in patients with nonvalvular atrial fibrillation: a review of pharmacokinetics, safety, efficacy, quality of life, and cost effectiveness
- (2014) Helen Mani et al. Drug Design Development and Therapy
- The PRISMA Statement for Reporting Systematic Reviews and Meta-Analyses of Studies That Evaluate Health Care Interventions: Explanation and Elaboration
- (2013) Alessandro Liberati ANNALS OF INTERNAL MEDICINE
- Treatment of cancer-associated thrombosis
- (2013) A. Y. Y. Lee et al. BLOOD
- Worldwide Epidemiology of Atrial Fibrillation
- (2013) Sumeet S. Chugh et al. CIRCULATION
- The P-Glycoprotein Transport System and Cardiovascular Drugs
- (2013) Jeffrey D. Wessler et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Insights Into Onco-Cardiology
- (2013) Dimitrios Farmakis et al. JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY
- Comparison of the efficacy and safety of new oral anticoagulants with warfarin in patients with atrial fibrillation: a meta-analysis of randomised trials
- (2013) Christian T Ruff et al. LANCET
- Efficacy and Safety of the Novel Oral Anticoagulants in Atrial Fibrillation
- (2012) Francesco Dentali et al. CIRCULATION
- Cancer drugs and the heart: importance and management
- (2012) T. M. Suter et al. EUROPEAN HEART JOURNAL
- A randomized phase II trial of apixaban for the prevention of thromboembolism in patients with metastatic cancer
- (2012) M. N. LEVINE et al. JOURNAL OF THROMBOSIS AND HAEMOSTASIS
- Bleeding risk assessment and management in atrial fibrillation patients: a position document from the European Heart Rhythm Association, endorsed by the European Society of Cardiology Working Group on Thrombosis
- (2011) G. Y. H. Lip et al. EUROPACE
- Graphical methods and numerical summaries for presenting results from multiple-treatment meta-analysis: an overview and tutorial
- (2010) Georgia Salanti et al. JOURNAL OF CLINICAL EPIDEMIOLOGY
- Procoagulant mechanisms in tumour cells
- (2009) Anna Falanga et al. BEST PRACTICE & RESEARCH CLINICAL HAEMATOLOGY
- Dabigatran versus Warfarin in Patients with Atrial Fibrillation
- (2009) Stuart J. Connolly et al. NEW ENGLAND JOURNAL OF MEDICINE
Find Funding. Review Successful Grants.
Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.
ExploreDiscover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversation